M&T Bank Corporation vs Twist Bioscience Corp — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: M&T Bank Corporation is far larger — about 6.6× Twist Bioscience Corp's market cap, and M&T Bank Corporation pays a 2.41% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| MTB | TWST | |
|---|---|---|
Market Cap | $36.15B | $5.45B |
Sector | Financials | Health |
52-Week High | $254.04 | $102.88 |
52-Week Low | $178.63 | $24.16 |
Dividend Yield | 2.41% | — |
Enterprise Value | — | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →